pre-treatment value in patients with varicella infection 167 × 103 U/ml (age:
3–17 years). In the AC
MEAD, G.E.,
LEGG, L.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.,
DENNIS, M.S.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J. (2020) ). There was no difference in the proportion independent (
3 trials, n = 3249, 36.6% fluoxetine vs. 36.7% control; RR 1.00, 95
Isaeva, A.,
Averyanov, S.,
Iskhakov, I.,
Gulyaeva, O.,
Gileva, O.,
Kiniabaev, T. (2020) - 0.42 +/- 0.03; PMA - 9.92 +/- 1.42%) evaluated in
3rd, 6th and 12th months after the therapy